Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 7,436 shares at $23.05 ($171K) on 2022-01-06, disclosed to the SEC on 2022-01-10.
Open-market sale of $171k ACAD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.05 | 3,718 | $86K | 50.0% |
| 2 | $23.05 | 3,718 | $86K | 50.0% |
| Total | $23.05 avg | 7,436 | $171K | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |